Detail

Keywords

Artificial Intelligence; Medical Physics; Radiation Oncology

Research group(s)

• Medical Radiation Research
  Head: Dietmar Georg
  Research Area: The vision of our group is the optimization of the treatment outcome of radiation oncology, alone or in combination with established chemotherapy or novel targeted strategies of drug treatment, with conventional photon or innovative ion-beams.
  Members:
  Nicole Nesvacil
  Andreas Renner
  Gerd Heilemann
  Wolfgang Lechner
  Sylvia Gruber
  Monika Clausen
  Stefan Ecker
  Andreas Resch
  Petra Trnkova
  Natalia Kostiukhina
  Dietmar Georg
  Barbara Knäusl
  Hermann Fuchs
  Ingo Gulyas
  Elisabeth S. Gruber
  Peter Kuess

Selected publications

1. Heilemann, G. et al., 2018. Retina dose as a predictor for visual acuity loss in 106 Ru eye plaque brachytherapy of uveal melanomas. Radiotherapy and Oncology, 127(3), pp.379-384. Available at: http://dx.doi.org/10.1016/j.radonc.2017.11.010.
2. Heilemann, G. et al., 2017. Treatment plan optimization and robustness of 106 Ru eye plaque brachytherapy using a novel software tool. Radiotherapy and Oncology, 123(1), pp.119-124. Available at: http://dx.doi.org/10.1016/j.radonc.2017.01.010.
3. Heilemann, G. et al., 2015. Multidimensional dosimetry of 106Ru eye plaques using EBT3 films and its impact on treatment planning. Medical Physics, 42(10), pp.5798-5808. Available at: http://dx.doi.org/10.1118/1.4929564.
4. Heilemann, G., Poppe, B. & Laub, W., 2013. On the sensitivity of common gamma-index evaluation methods to MLC misalignments in Rapidarc quality assurance. Medical Physics, 40(3), p.031702. Available at: http://dx.doi.org/10.1118/1.4789580.